TRLVNYSEMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Trulieve Cannabis Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$10.28+0.27 (+2.70%)
Close on Oct 19, 2026
- Market cap
- $1.98B
- P/E (TTM)
- –
- Dividend yield
- –
Trulieve Cannabis Corp. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Retail | $254.92M | $265.17M | $273.80M | $270.79M | $283.88M | $281.97M | $285.33M | $269.24M | $289.31M | $284.99M | $273.65M | $263.17M | 94.1% | -10.2% |
| Wholesale and other | $16.03M | $21.59M | – | $17.40M | $18.21M | $15.79M | – | $15.05M | $14.13M | $12.63M | $12.93M | $11.55M | 5.9% | -11.9% |
| Wholesale, Licensing and Other | – | – | – | – | – | – | – | – | – | – | – | $12.04M | – | – |
| Licensing and Other | – | – | – | – | – | – | – | $462.00K | $459.00K | $446.00K | $398.00K | $492.00K | – | – |
By region
From the segment and revenue-disaggregation notes of Trulieve Cannabis's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.